PDIA4 and prostate carcinoma: It was revealed that modulating PDIA4 expression in cancer cells allowed the cells to grow by regulating caspase 3 and 7, docetaxel resistance was induced by PDIA4 activation and inhibited prostate cancer cell apoptosis, while PDIA4 inactivation restored classical mitochondrial apoptosis [40–42].